Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal Staining

This study has been completed.
Information provided by:
Innovative Medical
ClinicalTrials.gov Identifier:
First received: June 1, 2007
Last updated: July 23, 2007
Last verified: July 2007

To evaluate corneal staining after contact lens instillation with two different multi purpose solutions.

Condition Intervention Phase
Corneal Staining
Drug: sodium citrate, sodium chloride, sodium borate, propylene glycol. citrate, tetronic 1304, AMP 95
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind

Resource links provided by NLM:

Further study details as provided by Innovative Medical:


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both

Inclusion Criteria:

  • Patients 18 yrs or older
  • Males or females
  • Any race or ethnic background
  • CL patients using (multipurpose solutions) MPS
  • Patients using Acuvue 2 lenses

Exclusion Criteria:

  • Corneal refractive surgery within 6 months of this study.
  • Contact lens use on day of examination.
  • Corneal ectasia.
  • Current use of Restasis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00483795

United States, Pennsylvania
Hazleton Eye Specialists
Hazleton, Pennsylvania, United States, 18202
Sponsors and Collaborators
Innovative Medical
Principal Investigator: Thomas Kislan, OD Hazleton Eye Specialists
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00483795     History of Changes
Other Study ID Numbers: 5308
Study First Received: June 1, 2007
Last Updated: July 23, 2007
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Citric Acid
Hematologic Agents
Therapeutic Uses
Pharmacologic Actions
Chelating Agents
Molecular Mechanisms of Pharmacological Action

ClinicalTrials.gov processed this record on April 16, 2014